Video

Portfolio Manager, Vihari Ross and Investment Director, Alison Savas provide a market and portfolio positioning update for Q3 2025. 
The investment case for Brazil’s Nubank.
With a 20% discount to the S&P 500 and faster growth than peers, Alphabet represents a classic mispriced opportunity for pragmatic investors seeking growth at a relative discount.
Watch a feature interview with Antipodes CIO Jacob Mitchell on Livewire Markets.
A replay of Jacob Mitchell’s presentation at the 2025 Pinnacle Investment Summit, held in July 2025. 
Antipodes portfolio manager, Nick Cameron, outlines the investment case for US medical device company, Globus Medical.

Coming soon to the ASX: the Antipodes Global SMID Fund will be available as an active ETF on the 10th of November 2025

X